About Owen Mumford
Owen Mumford is a company based in Oxford (United Kingdom) founded in 1952 by Thomas Owen, John Mumford, and Ivan Owen was acquired by Embecta in March 2026. Owen Mumford has completed 1 acquisition, including Empelvic. Owen Mumford offers products and services including Unifine® Syringes, Aidaptus® Auto-Injector, Unistik® Devices, and Empelvic. Owen Mumford operates in a competitive market with competitors including Flat Medical, Stable Pharma, Retractable Technologies, KORU Medical Systems and NuGen MD, among others.
- Headquarter Oxford, United Kingdom
- Founders Thomas Owen, John Mumford, Ivan Owen
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Owen Mumford Limited
- Date of Incorporation 10 May, 1976
- Jurisdiction WOODSTOCK, OXFORDSHIRE
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Owen Mumford
Owen Mumford offers a comprehensive portfolio of products and services, including Unifine® Syringes, Aidaptus® Auto-Injector, Unistik® Devices, and Empelvic.
Devices for safe medical injections and blood collection
Tool for drug delivery with patient-centric safety features
Lancets for blood sampling and testing procedures
Product for pelvic health exercises and support
Funding Insights of Owen Mumford
Investors in Owen Mumford
Owen Mumford has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Embecta and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked | |
|
Insulin delivery solutions including pen needles and syringes are manufactured.
|
Locked | Locked | Locked |
Investor details for Owen Mumford
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Owen Mumford
Owen Mumford has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Empelvic.
Investment portfolio details for Owen Mumford
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of pelvic floor training device for women
|
Locked | Locked | 2018 | Locked |
Complete acquisition details for Owen Mumford
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Owen Mumford
Detailed financials for Owen Mumford
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Owen Mumford Comparisons
Peer comparison for Owen Mumford
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Owen Mumford
Owen Mumford operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Flat Medical, Stable Pharma, Retractable Technologies, KORU Medical Systems and NuGen MD, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Epidural injection syringes with pressure detection are manufactured.
|
|
| Locked | Locked | Locked |
Developer of technology to store and deliver stable drugs and vaccines
|
|
| Locked | Locked | Locked |
Provides portfolio of smart syringes and needles to prevent from needle-stick injuries
|
|
| Locked | Locked | Locked |
Infusion systems and accessories for subcutaneous drug administration are manufactured.
|
|
| Locked | Locked | Locked |
Developer of needle-free drug delivery system
|
Detailed competitors of Owen Mumford
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Owen Mumford
Complete news archive for Owen Mumford
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Owen Mumford
Owen Mumford was founded in 1952 and raised its 1st funding round 68 years after it was founded.
Owen Mumford is headquartered in Oxford, United Kingdom. It is registered at Oxford, Oxfordshire, United Kingdom.
Owen Mumford was established in 1952 in Oxford, United Kingdom, within the medical devices sector. Operations focus on producing disposables for drug delivery and capillary blood sampling across multiple therapeutic areas. Items such as Unistik, Autopen, Autoject, and Unifine Pentips are developed, alongside proprietary lancets, lancing devices, and safety lancets for blood sampling applications. Distribution occurs globally from the UK base.
Owen Mumford's top competitors include KORU Medical Systems, Stable Pharma and Flat Medical.
Owen Mumford offers Unifine® Syringes, Aidaptus® Auto-Injector, Unistik® Devices, and Empelvic.
Owen Mumford has made 1 acquisition, including Empelvic.
Owen Mumford has 2 investors. Key investors include Embecta, and European Union.